Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma (Q73580678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Quynh-Thu Le

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

David Tate

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Iris C Gibbs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Steven D Chang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

John R Adler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Harlan A Pinto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

David J Terris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Willard E Fee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Don R Goffinet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1046-1054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Radiosurgery for skull base malignancies and nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Linear Accelerator as a Neurosurgical Tool for Stereotactic Radiosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Dose-response analysis for nasopharyngeal carcinoma: an historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

The role of brachytherapy in early-stage nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Fractionated stereotactic radiation therapy for extracranial head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Linear accelerator based radiosurgery as a salvage treatment for skull base and intracranial invasion of recurrent nasopharyngeal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900117-2

7 January 2021

10.1016/S0360-3016(03)00117-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12829140%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference